By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a



Company News
Capricor Therapeutics, Inc. Reports Second Quarter 2014 Financial & Business Highlights 8/13/2014 12:32:26 PM
Capricor Therapeutics, Inc. To Hold Second Quarter 2014 Business Update Conference Call On August 13, 2014 At 4:30 P.M. Eastern Time 8/4/2014 8:21:03 AM
Capricor Therapeutics, Inc. Announces Encouraging Results From Phase1 ALLSTAR Trial; Phase 2 Trial Underway 7/16/2014 6:07:12 AM
Capricor Therapeutics, Inc. To Present At The First Regenerative Medicine Forum At Biotechnology Industry Organization (BIO) International Convention 6/23/2014 10:53:06 AM
Capricor Therapeutics, Inc. Speaks At Panel On Regulation Of Stem Cell-Derived Therapeutic Products At Drug Information Association 2014 50th Annual Meeting 6/20/2014 8:35:13 AM
Capricor Therapeutics, Inc. To Present On Exosomes As A Basis For Innovative Platform Technology At 11th International Symposium On Stem Cell Therapy And Cardiovascular Innovations 5/29/2014 9:29:37 AM
Capricor Therapeutics, Inc. Enters Into Exclusive License With Cedars-Sinai Medical Center For Exosome-Related IP Portfolio 5/7/2014 9:12:06 AM
Capricor Therapeutics, Inc. To Present ALLSTAR Phase I Trial Data At American College of Cardiology Annual Meeting 2014 3/31/2014 9:27:49 AM
Capricor Therapeutics, Inc. To Present At Two Upcoming Investor Conferences 3/11/2014 9:14:32 AM
Little Biotech, Capricor Therapeutics, Inc. Inks Heart Pact Worth $337.5 Million With Johnson & Johnson (JNJ)'s Janssen Biotech Inc. (JNJ) 1/6/2014 7:32:53 AM